Literature DB >> 19782028

Histone chaperones ASF1 and NAP1 differentially modulate removal of active histone marks by LID-RPD3 complexes during NOTCH silencing.

Yuri M Moshkin1, Tsung Wai Kan, Henry Goodfellow, Karel Bezstarosti, Robert K Maeda, Maxim Pilyugin, Francois Karch, Sarah J Bray, Jeroen A A Demmers, C Peter Verrijzer.   

Abstract

Histone chaperones are involved in a variety of chromatin transactions. By a proteomics survey, we identified the interaction networks of histone chaperones ASF1, CAF1, HIRA, and NAP1. Here, we analyzed the cooperation of H3/H4 chaperone ASF1 and H2A/H2B chaperone NAP1 with two closely related silencing complexes: LAF and RLAF. NAP1 binds RPD3 and LID-associated factors (RLAF) comprising histone deacetylase RPD3, histone H3K4 demethylase LID/KDM5, SIN3A, PF1, EMSY, and MRG15. ASF1 binds LAF, a similar complex lacking RPD3. ASF1 and NAP1 link, respectively, LAF and RLAF to the DNA-binding Su(H)/Hairless complex, which targets the E(spl) NOTCH-regulated genes. ASF1 facilitates gene-selective removal of the H3K4me3 mark by LAF but has no effect on H3 deacetylation. NAP1 directs high nucleosome density near E(spl) control elements and mediates both H3 deacetylation and H3K4me3 demethylation by RLAF. We conclude that histone chaperones ASF1 and NAP1 differentially modulate local chromatin structure during gene-selective silencing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782028     DOI: 10.1016/j.molcel.2009.07.020

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  81 in total

1.  Histone demethylase KDM5A is an integral part of the core Notch-RBP-J repressor complex.

Authors:  Robert Liefke; Franz Oswald; Cristobal Alvarado; Dolores Ferres-Marco; Gerhard Mittler; Patrick Rodriguez; Maria Dominguez; Tilman Borggrefe
Journal:  Genes Dev       Date:  2010-03-15       Impact factor: 11.361

Review 2.  The epigenetics of germ-line immortality: lessons from an elegant model system.

Authors:  Hirofumi Furuhashi; William G Kelly
Journal:  Dev Growth Differ       Date:  2010-08       Impact factor: 2.053

3.  Selective targeting of histone methylation.

Authors:  Abul B M M K Islam; William F Richter; Nuria Lopez-Bigas; Elizaveta V Benevolenskaya
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

4.  KDM5B regulates embryonic stem cell self-renewal and represses cryptic intragenic transcription.

Authors:  Liangqi Xie; Carl Pelz; Wensi Wang; Amir Bashar; Olga Varlamova; Sean Shadle; Soren Impey
Journal:  EMBO J       Date:  2011-03-29       Impact factor: 11.598

5.  A SirT'N repression for Notch.

Authors:  Katherine A Jones
Journal:  Mol Cell       Date:  2011-06-10       Impact factor: 17.970

Review 6.  Flickin' the ubiquitin switch: the role of H2B ubiquitylation in development.

Authors:  Duncan Edward Wright; Chen-Yi Wang; Cheng-Fu Kao
Journal:  Epigenetics       Date:  2011-10-01       Impact factor: 4.528

7.  The complex roles of histone demethylases in vivo.

Authors:  Luisa Di Stefano; Nicholas J Dyson
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

Review 8.  Integration of Drosophila and Human Genetics to Understand Notch Signaling Related Diseases.

Authors:  Jose L Salazar; Shinya Yamamoto
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

9.  Histone chaperone ASF1B promotes human β-cell proliferation via recruitment of histone H3.3.

Authors:  Pradyut K Paul; Mary E Rabaglia; Chen-Yu Wang; Donald S Stapleton; Ning Leng; Christina Kendziorski; Peter W Lewis; Mark P Keller; Alan D Attie
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

10.  Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer.

Authors:  Ioannis Sanidas; Christos Polytarchou; Maria Hatziapostolou; Scott A Ezell; Filippos Kottakis; Lan Hu; Ailan Guo; Jianxin Xie; Michael J Comb; Dimitrios Iliopoulos; Philip N Tsichlis
Journal:  Mol Cell       Date:  2014-01-23       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.